Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)

Completed

Conditions studied: Atrial Fibrillation

In brief

The ORBIT-AF registry will be a multicenter, prospective outpatient disease registry to identify "real world" treatment patterns of atrial fibrillation. The registry will describe this patient population with regards to demographics, clinical factors, risk stratification, and geographic regions. In particular, attention will be focused on the utilization, effectiveness, and safety of antithrombotic therapies in the prevention of stroke. The registry is designed to identify reasons and risk factors for non-receipt of anticoagulation (AC) therapy, as well as reasons why AF patients who are prescribed AC therapy do not take them.

Key facts

Study ID

NCT01165710

Run by

Janssen Scientific Affairs, LLC

People needed

10179

Starts

2010-06-01

Expected to finish

2014-12-01

Last updated by the study team

2017-01-24

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients with incident (initial diagnosis) or prevalent (existing diagnosis) AF with electrocardiographic documentation
• anticipated ability to adhere to local regularly scheduled follow-up visits

You may not qualify if…

• Anticipated life expectancy less than 6 months
• short lasting AF secondary to a reversible condition (e.g. hyperthyroidism, pulmonary embolism, post-cardiothoracic surgery)
• Participation in a randomized trial of anticoagulation for AF at the time of enrollment

Where it is running

• Study site — Dothan, Alabama, United States
• Study site — Huntsville, Alabama, United States
• Study site — Mobile, Alabama, United States
• Study site — Montgomery, Alabama, United States
• Study site — Pell City, Alabama, United States
• Study site — Tuscaloosa, Alabama, United States
• Study site — Cottonwood, Arizona, United States
• Study site — Tucson, Arizona, United States
• Study site — Fort Smith, Arkansas, United States
• Study site — Carlsbad, California, United States
• Study site — Carmichael, California, United States
• Study site — Corona, California, United States
• Study site — Laguna Hills, California, United States
• Study site — Long Beach, California, United States
• Study site — Los Alamitos, California, United States
• Study site — Los Angeles, California, United States
• Study site — Montebello, California, United States
• Study site — Northridge, California, United States
• Study site — Orange, California, United States
• Study site — Oxnard, California, United States
• Study site — Palo Alto, California, United States
• Study site — Pismo Beach, California, United States
• Study site — Pomona, California, United States
• Study site — San Diego, California, United States
• Study site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.